Cargando…
Functional Therapeutic Target Validation Using Pediatric Zebrafish Xenograft Models
SIMPLE SUMMARY: Despite the major progress of precision and personalized oncology, a significant therapeutic benefit is only achieved in cases with directly druggable genetic alterations. This highlights the need for additional methods that reliably predict each individual patient’s response in a cl...
Autores principales: | Gatzweiler, Charlotte, Ridinger, Johannes, Herter, Sonja, Gerloff, Xenia F., ElHarouni, Dina, Berker, Yannick, Imle, Roland, Schmitt, Lukas, Kreth, Sina, Stainczyk, Sabine, Ayhan, Simay, Najafi, Sara, Krunic, Damir, Frese, Karen, Meder, Benjamin, Reuss, David, Fiesel, Petra, Schramm, Kathrin, Blattner-Johnson, Mirjam, Jones, David T. W., Banito, Ana, Westermann, Frank, Oppermann, Sina, Milde, Till, Peterziel, Heike, Witt, Olaf, Oehme, Ina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834194/ https://www.ncbi.nlm.nih.gov/pubmed/35159116 http://dx.doi.org/10.3390/cancers14030849 |
Ejemplares similares
-
Combining APR-246 and HDAC-Inhibitors: A Novel Targeted Treatment Option for Neuroblastoma
por: Müller, Michael, et al.
Publicado: (2021) -
Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish Xenografts
por: Wrobel, Jagoda K, et al.
Publicado: (2020) -
Broad-Spectrum HDAC Inhibitors Promote Autophagy through FOXO Transcription Factors in Neuroblastoma
por: Körholz, Katharina, et al.
Publicado: (2021) -
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM
por: Peterziel, Heike, et al.
Publicado: (2022) -
OTHR-04. DEVELOPMENT OF A FUNCTIONAL PLATFORM FOR REAL-TIME PERSONALIZED DRUG SENSITIVITY PROFILING OF PATIENT-DERIVED 3D FRESH TUMOR TISSUE CULTURES IN THE PEDIATRIC PRECISION ONCOLOGY PROGRAM INFORM
por: Peterziel, Heike, et al.
Publicado: (2023)